News for hackers. Stuff that matters.

A comment on Goldman Sachs questions whether curing patients is a sustainable business model. Parent comment

Re:Goldman Sachs questions whether curing patients is a sust... by mbesto on Friday April 13, 2018 @11:06AM (#16830629)
"in the US" is a misnomer. It all depends on if the cost allocation (e.g. HR is pharma's largest cost) has and is attributed to the US.
[ Parent | on HN ]

There are no comments on this comment yet.